netFormulary NHS
Demonstration Formulary
 Search
 Results

Looking for Brentuximab vedotin found 11 matches


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA446: Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma (08.01.05)
link in drug section NICE TA446: Brentuximab vedotin for treating CD30-positive Hodgkin lymphomaBrentuximab vedotin for treating CD30-positive Hodgkin lymphoma (08.01.05)
link in drug section NICE TA478: Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma (08.01.05)
link in drug section NICE TA478: Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma (08.01.05)
link in drug section NICE TA524: Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma (08.01.05)
link in drug section NICE TA524: Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma (08.01.05)
link in drug section NICE TA577: Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma (08.01.05)
link in drug section NICE TA577: Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma (08.01.05)
link in drug section NICE TA594: Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal) (08.01.05)
link in drug section NICE TA594; Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal) (08.01.05)
link in drug section NICE TA641: Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma (08.01.05)


 
netFormulary